Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1967 1
1972 1
1974 4
1975 2
1976 3
1977 3
1978 3
1979 1
1980 3
1981 1
1982 3
1983 5
1984 6
1985 4
1986 1
1987 3
1988 4
1989 1
1990 2
1991 3
1992 2
1993 4
1994 3
1995 2
1996 9
1997 2
1998 3
1999 3
2000 2
2001 5
2002 4
2003 4
2004 2
2005 5
2006 2
2007 4
2008 1
2009 2
2010 5
2011 3
2012 11
2013 9
2014 4
2015 5
2016 6
2017 12
2018 13
2019 21
2020 9
2021 10
2022 13
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B; CheckMate 214 Investigators. Motzer RJ, et al. N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21. N Engl J Med. 2018. PMID: 29562145 Free PMC article. Clinical Trial.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators. Bellmunt J, et al. N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17. N Engl J Med. 2017. PMID: 28212060 Free PMC article. Clinical Trial.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Free PMC article. Clinical Trial.
Reply by Authors.
McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, De Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Le Normand L, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB. McCrery R, et al. J Urol. 2020 Jan;203(1):192. doi: 10.1097/01.JU.0000602784.69147.96. Epub 2019 Oct 3. J Urol. 2020. PMID: 31580190 No abstract available.
Nonaromatic Organonickel(II) Phototheranostics.
Yao Y, Ran G, Hou CL, Zhang R, Mangel DN, Yang ZS, Zhu M, Zhang W, Zhang J, Sessler JL, Gao S, Zhang JL. Yao Y, et al. J Am Chem Soc. 2022 Apr 27;144(16):7346-7356. doi: 10.1021/jacs.2c00710. Epub 2022 Apr 14. J Am Chem Soc. 2022. PMID: 35420807
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
Schmid P, Abraham J, Chan S, Wheatley D, Brunt AM, Nemsadze G, Baird RD, Park YH, Hall PS, Perren T, Stein RC, Mangel L, Ferrero JM, Phillips M, Conibear J, Cortes J, Foxley A, de Bruin EC, McEwen R, Stetson D, Dougherty B, Sarker SJ, Prendergast A, McLaughlin-Callan M, Burgess M, Lawrence C, Cartwright H, Mousa K, Turner NC. Schmid P, et al. J Clin Oncol. 2020 Feb 10;38(5):423-433. doi: 10.1200/JCO.19.00368. Epub 2019 Dec 16. J Clin Oncol. 2020. PMID: 31841354 Free article. Clinical Trial.
Glycolytic shift during West Nile virus infection provides new therapeutic opportunities.
Mingo-Casas P, Blázquez AB, Gómez de Cedrón M, San-Félix A, Molina S, Escribano-Romero E, Calvo-Pinilla E, Jiménez de Oya N, Ramírez de Molina A, Saiz JC, Pérez-Pérez MJ, Martín-Acebes MA. Mingo-Casas P, et al. J Neuroinflammation. 2023 Sep 27;20(1):217. doi: 10.1186/s12974-023-02899-3. J Neuroinflammation. 2023. PMID: 37759218 Free PMC article.
[The brown tumour in untreated hyperparathyroidism].
Gerber FA, Rupp NJ, Döbelin Q, Stadlinger B, Valdec S. Gerber FA, et al. Swiss Dent J. 2022 Mar 7;132(3):190-191. doi: 10.61872/sdj-2022-03-03. Swiss Dent J. 2022. PMID: 35285591 Free article. German.
Complex adaptive systems, aging and longevity.
Mangel M. Mangel M. J Theor Biol. 2001 Dec 21;213(4):559-71. doi: 10.1006/jtbi.2001.2431. J Theor Biol. 2001. PMID: 11742525 Review.
I show how dynamic state variable models based on stochastic dynamic programming (Clark & Mangel, 2000) can be used to embed genetic theories of senescence (either mutation accumulation or antagonistic pleiotropy) in the somatic environment, as George Williams called f …
I show how dynamic state variable models based on stochastic dynamic programming (Clark & Mangel, 2000) can be used to embed gene …
Postinfectious IBS.
Mangel AW. Mangel AW. Am J Gastroenterol. 2005 Mar;100(3):729; author reply 729-30. doi: 10.1111/j.1572-0241.2005.t01-4-41461.x. Am J Gastroenterol. 2005. PMID: 15743380 No abstract available.
223 results